1-2 of 2
Chunling Hu
Close
Sort by
Journal Articles

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair

Jithma P. Abeykoon, Xiaosheng Wu, Kevin E. Nowakowski, Surendra Dasari, Jonas Paludo, S. John Weroha, Chunling Hu, Xiaonan Hou, Jann N. Sarkaria, Ann C. Mladek, Jessica L. Phillips, Andrew L. Feldman, Aishwarya Ravindran, Rebecca L. King, Justin Boysen, Mary J. Stenson, Ryan M. Carr, Michelle K. Manske, Julian R. Molina, Prashant Kapoor, Sameer A. Parikh, Shaji Kumar, Steven I. Robinson, Jia Yu, Judy C. Boughey, Liewei Wang, Matthew P. Goetz, Fergus J. Couch, Mrinal M. Patnaik, Thomas E. Witzig
Journal: Blood
Blood (2021) 137 (4): 513–523.
https://doi.org/10.1182/blood.2020009013
Published: 2021
Includes: Supplemental data
Journal Articles

Salicylates Potentiate and Broaden CRM1 Inhibitor Anti-Tumor Activity Via S-Phase Arrest and Impaired DNA-Damage Repair

Jithma P. Abeykoon, MD, Xiaosheng Wu, MD, Kevin E. Nowakowski, Surendra Dasari, PhD, Jonas Paludo, MD, S. John Weroha, Chunling Hu, PhD, Jann Sarkaria, Ann Mladek, Jessica Phillips, PhD, Andrew L. Feldman, MD, Aishwarya Ravindran, MBBS, Rebecca L. King, MD, Mary J. Stenson, Michelle Manske, MS, BS, Fergus Couch, Mrinal M. Patnaik, MDMBBS, Thomas E. Witzig, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-138619
Published: 2020